Digitalized Precision Medicine
Genedata Profiler
Mass Spec Analytics. One Enterprise Solution.
Genedata Expressionist
Biopharmaceutical Discovery Workflow Platform
Genedata Biologics
Designing Next-Generation Bioprocesses
Genedata Bioprocess
Digitalized Solutions for Lab Automation
Genedata Screener
NGS Analyses. GxP-Ready. Unlimited.
Genedata Selector
Accessible and Limitless NGS Analyses
All Assays. One Digital Platform
Genedata Biopharma Platform: Digitalizing R&D
Screener Biotherapeutics Assay Analysis
In-House Validation of NGS-Based Assays
End-to-End Digital Solution for NGS Labs
NGS for Nanobody Discovery and Development
Applications of Long-Read Sequencing in Biopharma R&D
Validation Framework for NGS Assays in Viral Safety Testing
Off-the-Shelf Analysis Solution for GMP-Compliant NGS Assays
Connecting the Dots for NGS in GMP Environments
NGS-Based Biosafety Assays in GMP
Introduction Video - Genedata Biologics for Biopharma Discovery
Genedata Selector for Precise Genome Editing
The Opportunities and Challenges in Cell Therapy Development
10 Steps to an NGS-Based Biosafety Assay
Japan: JBA "Right Drug to Right Patient"
The Power of Data in Cell Therapy Development
Autologous and Allogeneic Cell Therapies
Cell Therapy and Its Applications
Genedata Selector for NGS-Based Biosafety Testing
Genedata Selector for Cell Line & Bioprocess Development
Streamlining Biopharma Mass Spectrometry Processes
Enterprise Software for all NGS-Based Workflows
Introduction Video - Genedata Bioprocess for Next-Gen Manufacturing
Using Precision Medicine Concepts to Improve Clinical Trials